Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insul... (chnology is based on over 25 years of re...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule

Date:8/6/2008

chnology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals

Eric Rosenberg

Cell: +972-54-566-7713

Office: +972-2-566-0001

Email: eric@oramed.com

Media Contacts:

Ruder Finn Israel for Oramed

Matthew Krieger

Cell: +972-54-467-6950

Office: +972-2-589-2003

Email: matthew@oramed.com

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
3. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
4. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
5. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
7. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
8. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
9. BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
10. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
11. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

Post Your Comments:

Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2 BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3 BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4 Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12 Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 1 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 2 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 3 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 4 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 5 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 6 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 7 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 8 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 9 Advanced Life Sciences Announces Third Quarter 2009 Financial Results 6130 10 Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 1 Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 2 Sigma Aldrich Enters Distribution Agreement With Stemgent Inc to Offer Lentivirus Based Gene Delivery Products for Regenerative Medicine and Stem Ce 6123 3 Climate studies to benefit from 12 years of satellite aerosol data 61062 1 Climate studies to benefit from 12 years of satellite aerosol data 61062 2

[0] BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors [0] Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research [0] Helix BioPharma Corp. Announces Fiscal Q1 2010 Results

Other Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2 Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3 Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4 Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5

Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma

Breaking Medicine News(10 mins):Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2 Health News:States Slash Funding for Tobacco Prevention Programs 2 Health News:States Slash Funding for Tobacco Prevention Programs 3 Health News:All-New TendoFlex(TM) Revolutionizes Stretching and Core Strengthening 2 Health News:The Concord Grape Commands Attention at Major Scientific Conference 2 Health News:The Concord Grape Commands Attention at Major Scientific Conference 3 Health News:The Concord Grape Commands Attention at Major Scientific Conference 4 Health News:The Concord Grape Commands Attention at Major Scientific Conference 5 Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2 Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3

[0] Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research [0] States Slash Funding for Tobacco Prevention Programs [1] All-New TendoFlex(TM) Revolutionizes Stretching and Core Strengthening [1] The Concord Grape Commands Attention at Major Scientific Conference [0] Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report

Other Medicine News:Health News:Study shows ultrasound and tPA effective for stroke 2 Health News:Lifetime Caps Bill Introduced 2 Health News:Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act 2 Health News:Frost & Sullivan Recognizes WCC for Its Unique Multimodal Platform 2 Health News:Frost & Sullivan Recognizes WCC for Its Unique Multimodal Platform 3 Health News:Frost & Sullivan Recognizes WCC for Its Unique Multimodal Platform 4 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 2 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 3 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 4 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 5 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 6 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 7 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 8 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 9 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 10 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 11 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 12 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 13 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 14 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 15 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 16 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 17 Health News:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook 18 Health News:Musculoskeletal Clinical Regulatory Advisers, LLC Announces Signing of its 100th Client 2

Study shows ultrasound and tPA effective for stroke Lifetime Caps Bill Introduced Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act Frost & Sullivan Recognizes WCC for Its Unique Multimodal Platform Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook Musculoskeletal Clinical Regulatory Advisers, LLC Announces Signing of its 100th Client

Medicine Products:

ART Self-Sealing Barrier Tips, 10 l Eppendorf Filtertips, 2.5 l, sterile, and PCR Clean RNase-free Tips, 1000 l size Finntip Wide 100-1000 L